{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T09:39:01Z","timestamp":1782553141987,"version":"3.54.5"},"reference-count":112,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semdiagpath.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1053\/j.semdp.2017.04.009","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T18:16:58Z","timestamp":1494008218000},"page":"377-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["HIV associated kidney diseases: Clarifying concordance between renal failure in HIV infection and histopathologic manifestations at kidney biopsy"],"prefix":"10.1053","volume":"34","author":[{"given":"Carla L.","family":"Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.semdp.2017.04.009_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1468-1293.2008.00691.x","article-title":"Spectrum of chronic kidney disease in HIV-infected patients","volume":"10","author":"Campbell","year":"2009","journal-title":"HIV Med"},{"issue":"18","key":"10.1053\/j.semdp.2017.04.009_bib2","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1097\/QAD.0b013e32827038ad","article-title":"End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV seronegative participants followed between 1998 and 2004","volume":"21","author":"Lucas","year":"2007","journal-title":"AIDS"},{"issue":"8","key":"10.1053\/j.semdp.2017.04.009_bib3","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1681\/ASN.2005040340","article-title":"Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease","volume":"16","author":"Schwartz","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.semdp.2017.04.009_bib4","first-page":"87","article-title":"HIV-associated nephropathy. A unique combined glomerular, tubular and interstitial lesion","volume":"1","author":"Cohen","year":"1988","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.04.009_bib5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/01913123.2013.814738","article-title":"The clinicopathologic significance of endothelial tubuloreticular inclusions in glomerular diseases","volume":"37","author":"Lee","year":"2013","journal-title":"Ultrastruct Pathol"},{"key":"10.1053\/j.semdp.2017.04.009_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2215\/CJN.07311009","article-title":"Treatment with IFN-alpha, beta or gamma is associated with collapsing focal segmental glomerulosclerosis","volume":"5","author":"Markowitz","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.semdp.2017.04.009_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3109\/01913128709048453","article-title":"The relationship of serum alpha-interferon and ulstrastructural markers in HIV-seropositive individuals","volume":"11","author":"Orenstein","year":"1987","journal-title":"Ultrastruct Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2017.04.009_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.ackd.2009.08.012","article-title":"The pathogenesis of HIV-associated nephropathy","volume":"17","author":"Kaufman","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"10.1053\/j.semdp.2017.04.009_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.ackd.2009.08.005","article-title":"Diagnosis and natural history of HIV-associated Nephropathy","volume":"17","author":"Atta","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"issue":"11","key":"10.1053\/j.semdp.2017.04.009_bib10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1056\/NEJM198403153101101","article-title":"Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome","volume":"310","author":"Rao","year":"1984","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.semdp.2017.04.009_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0002-9343(89)80819-8","article-title":"Course and prognosis of human immunodeficiency virus-associated nephropathy","volume":"87","author":"Carbone","year":"1989","journal-title":"Am J Med"},{"issue":"1","key":"10.1053\/j.semdp.2017.04.009_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archinte.1991.00400010131019","article-title":"Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy","volume":"151","author":"Cantor","year":"1991","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1053\/j.semdp.2017.04.009_bib13","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1681\/ASN.V9122327","article-title":"HIV associated nephropathy: outcome and prognosis factors. Groupe d\u2019Etudes Nephrologiques d\u2019Ile de France","volume":"9","author":"Laradi","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.semdp.2017.04.009_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/sti.74.3.179","article-title":"Presentation, pathology and outcome of HIV associated renal disease in a specialist center for HIV\/AIDS","volume":"74","author":"Williams","year":"1998","journal-title":"Sex Transm Infect"},{"issue":"5","key":"10.1053\/j.semdp.2017.04.009_bib15","first-page":"377","article-title":"Human immunodeficiency virus\/acquired immunodeficiency syndrome-associated nephropathy at end stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era","volume":"14","author":"Abbot","year":"2001","journal-title":"J Nephrol"},{"key":"10.1053\/j.semdp.2017.04.009_bib16","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1046\/j.1523-1755.63.s83.10.x","article-title":"HIV-associated nephropathy in African Americans","volume":"83","author":"Kopp","year":"2003","journal-title":"Kidney Int Suppl"},{"issue":"9","key":"10.1053\/j.semdp.2017.04.009_bib17","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1097\/01.ASN.0000138546.53152.A7","article-title":"Is there an epidemic of HIV infection in the US ESRD program?","volume":"15","author":"Eggers","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.semdp.2017.04.009_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oxfordjournals.ndt.a092263","article-title":"Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals","volume":"8","author":"Nochy","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.semdp.2017.04.009_bib19","first-page":"269","article-title":"Renal lesions associated with human immunodeficiency virus infection: North American vs European experience","volume":"22","author":"Nochy","year":"1993","journal-title":"Adv Nephrol Necker Hosp"},{"issue":"11","key":"10.1053\/j.semdp.2017.04.009_bib20","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1086\/587994","article-title":"Chronic kidney disease incidence and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races","volume":"197","author":"Lucas","year":"2008","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1053\/j.semdp.2017.04.009_bib21","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.semdp.2017.04.009_bib22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ki.2012.111","article-title":"HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics","volume":"82","author":"Atta","year":"2012","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.semdp.2017.04.009_bib23","doi-asserted-by":"crossref","first-page":"e5176","DOI":"10.1590\/1414-431X20165176","article-title":"Multiple facets of HIV-associated renal disease","volume":"49","author":"Da Silva","year":"2016","journal-title":"Braz J Med Biol Res"},{"issue":"5","key":"10.1053\/j.semdp.2017.04.009_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000332378","article-title":"Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population","volume":"34","author":"Behar","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.semdp.2017.04.009_bib25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1681\/ASN.2016111171","article-title":"HIV-1 infection of renal cells in HIV-associated nephropathy","volume":"28","author":"Bruggeman","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.semdp.2017.04.009_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oxfordjournals.ndt.a092263","article-title":"Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals","volume":"8","author":"Nochy","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.semdp.2017.04.009_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrneph.2015.216","article-title":"HIV-associated immune complex kidney disease","volume":"12","author":"Nobakht","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1053\/j.semdp.2017.04.009_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF01892090","article-title":"Glomerular response to immunologic injury, studies on progression","volume":"5","author":"Killen","year":"1982","journal-title":"Springe Semin Immunopathol"},{"key":"10.1053\/j.semdp.2017.04.009_bib29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ki.2014.49","article-title":"The etiology of glomerulonephritis: roles of infection and autoimmunity","volume":"86","author":"Couser","year":"2014","journal-title":"Kidney Int"},{"key":"10.1053\/j.semdp.2017.04.009_bib30","unstructured":"Kimmel PL, Phillips TM. In: Kimmel PL. et al., eds. Renal and Urologic Aspects of HIV Infection.\u00a0Churchill Livingstone; 1995:77-110."},{"key":"10.1053\/j.semdp.2017.04.009_bib31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1681\/ASN.2011030304","article-title":"Basic and translational concepts of immune-mediated glomerular diseases","volume":"23","author":"Couser","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.semdp.2017.04.009_bib32","unstructured":"Wilson CB, Dixon FJ. In: Brenner BM, Rector FC, eds. The Kidney. Saunders; 1976:838-940."},{"key":"10.1053\/j.semdp.2017.04.009_bib33","first-page":"529","article-title":"Immune complexes in human diseases","volume":"100","author":"Theophilopoulos","year":"1980","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2017.04.009_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oxfordjournals.ndt.a092263","article-title":"Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals","volume":"8","author":"Nochy","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.semdp.2017.04.009_bib35","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0140-6736(11)61645-0","article-title":"Rash diagnosis of blood expectoration","volume":"379","author":"Boissier","year":"2012","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2017.04.009_bib36","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0272-6386(95)90490-5","article-title":"Pattern of glomerular involvement in human immunodeficiency virus-infected patients: an Italian study","volume":"26","author":"Casanova","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.semdp.2017.04.009_bib37","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1523-1755.2005.00215.x","article-title":"HIV-associated immune complex glomerulonephritis with \u201clupus-like\u201d features. A clinicopathologic study of 14 cases","volume":"67","author":"Haas","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.semdp.2017.04.009_bib38","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/sj.ki.5000351","article-title":"HIV-related nephropathy: a South African perspective","volume":"69","author":"Gerntholz","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.semdp.2017.04.009_bib39","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.2215\/CJN.10991012","article-title":"Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy","volume":"8","author":"Foy","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.semdp.2017.04.009_bib40","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1523-1755.2004.00865.x","article-title":"The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection","volume":"66","author":"Szczech","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.semdp.2017.04.009_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/infdis\/162.1.21","article-title":"A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals","volume":"162","author":"Nishanian","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1053\/j.semdp.2017.04.009_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/jmv.1890300107","article-title":"Free and antibody\u2013complexed antigen and antibody profile in apparently health HIV seropositive individuals and in AIDS patients","volume":"30","author":"Portera","year":"1990","journal-title":"J Med Virol"},{"key":"10.1053\/j.semdp.2017.04.009_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-3083.1987.tb02230.x","article-title":"Characterization of specific immune complexes in HIV-related disorders","volume":"26","author":"Carini","year":"1987","journal-title":"Scand J Immunol"},{"key":"10.1053\/j.semdp.2017.04.009_bib44","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1172\/JCI113075","article-title":"Antibody response to human immunodeficiency virus in homosexual men. relation of antibody specificity titer, and isotype to clinical status, severity of immunodeficiency and disease progression","volume":"80","author":"McDougal","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semdp.2017.04.009_bib45","first-page":"1207","article-title":"Immune complexes in pediatric human immunodeficiency virus infection","volume":"144","author":"Ellaurie","year":"1990","journal-title":"Am J Dis Child"},{"key":"10.1053\/j.semdp.2017.04.009_bib46","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.1053\/j.ajkd.2006.06.007","article-title":"The uncertain significance of anti-glomerular basement membrane antibody among HIV-infected persons with kidney disease","volume":"48","author":"Szczech","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.semdp.2017.04.009_bib47","unstructured":"Kimmel PL. In: Nielson EG, Couser WB, eds. Immunologic Renal Diseases (2nd ed.). Lippincott Williams and Wilkins:1203\u20131223."},{"key":"10.1053\/j.semdp.2017.04.009_bib48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11904-010-0064-2","article-title":"Alterations of the B-cell response by HIV-1 replication","volume":"8","author":"Shen","year":"2011","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1053\/j.semdp.2017.04.009_bib49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM198308253090803","article-title":"Abnormalities of B-Cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome","volume":"309","author":"Lane","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2017.04.009_bib50","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.semnephrol.2008.08.006","article-title":"Immune complex renal disease and human immunodeficiency virus infection","volume":"28","author":"Cohen","year":"2008","journal-title":"Semin Nephrol"},{"key":"10.1053\/j.semdp.2017.04.009_bib51","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM199209033271006","article-title":"Brief Report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection","volume":"327","author":"Kimmel","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2017.04.009_bib52","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/ki.1993.386","article-title":"HIV-associated immune-mediated renal disease","volume":"44","author":"Kimmel","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/j.semdp.2017.04.009_bib53","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1093\/ndt\/gfr702","article-title":"The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations","volume":"27","author":"Wearne","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.semdp.2017.04.009_bib54","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-3083.2008.02143.x","article-title":"Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity","volume":"68","author":"Malak","year":"2008","journal-title":"Scand J Immunol"},{"issue":"6","key":"10.1053\/j.semdp.2017.04.009_bib55","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.semnephrol.2008.08.007","article-title":"Thrombotic microangiopathy and other glomerular disorders in the HIV-infected patient","volume":"28","author":"Fine","year":"2008","journal-title":"Semin Nephrol"},{"key":"10.1053\/j.semdp.2017.04.009_bib56","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/pmj.78.923.520","article-title":"HIV associated thrombotic microangiopathy","volume":"78","author":"Ahmed","year":"2002","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1053\/j.semdp.2017.04.009_bib57","first-page":"259","article-title":"Human immunodeficiency virus-associated thrombotic microangiopathies","volume":"33","author":"Giardin","year":"2012","journal-title":"Rev Med Interne"},{"issue":"8","key":"10.1053\/j.semdp.2017.04.009_bib58","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/apc.2016.0124","article-title":"Thrombotic Microangiopathy in the Setting of HIV Infection: a Case report and review of the differential diagnosis and therapy","volume":"30","author":"Saab","year":"2016","journal-title":"AIDS Patient Care STDs"},{"key":"10.1053\/j.semdp.2017.04.009_bib59","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1086\/597471","article-title":"Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura","volume":"48","author":"Benjamin","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1053\/j.semdp.2017.04.009_bib60","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ckj\/sfw035","article-title":"Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab","volume":"9","author":"Jin","year":"2016","journal-title":"Clin Kidney J"},{"issue":"152","key":"10.1053\/j.semdp.2017.04.009_bib61","first-page":"1","article-title":"Thrombotic microangiopathy as first manifestation of acute human immunodeficiency virus infection: a case report and review of the literature","volume":"10","author":"Sarmiento","year":"2016","journal-title":"J Med Case Rep"},{"key":"10.1053\/j.semdp.2017.04.009_bib62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0049-3848(87)90241-6","article-title":"Induction of endothelial cell procoagulant activity by cytomegalovirus infection","volume":"47","author":"Van Dam-Mieras","year":"1987","journal-title":"Thromb Res Suppl"},{"key":"10.1053\/j.semdp.2017.04.009_bib63","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/JVI.68.4.2297-2304.1994","article-title":"Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. The procoagulant response of cytomegalovirus infected endothelial cells","volume":"68","author":"Haagmans","year":"1994","journal-title":"J Virol"},{"key":"10.1053\/j.semdp.2017.04.009_bib64","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/clinids\/17.3.360","article-title":"Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus infection: demonstration of p24 antigen in endothelial cells","volume":"17","author":"Del Arco","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semdp.2017.04.009_bib65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10623320009072210","article-title":"The effects of HIV infection on endothelial function","volume":"7","author":"Chi","year":"2000","journal-title":"Endothelium"},{"issue":"1","key":"10.1053\/j.semdp.2017.04.009_bib66","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1128\/JVI.74.1.344-353.2000","article-title":"Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells","volume":"74","author":"Mitola","year":"2000","journal-title":"J Virol"},{"issue":"10","key":"10.1053\/j.semdp.2017.04.009_bib67","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1089\/aid.1998.14.825","article-title":"Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinas C- and cAMP dependent protein kinase pathways","volume":"14","author":"Zidovetzki","year":"1998","journal-title":"AIDS Res Hum Retrovir"},{"issue":"18","key":"10.1053\/j.semdp.2017.04.009_bib68","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1097\/00002030-199818000-00006","article-title":"HIV-1 gp 120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P","volume":"12","author":"Annuziata","year":"1998","journal-title":"AIDS"},{"issue":"3","key":"10.1053\/j.semdp.2017.04.009_bib69","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1182\/blood.V87.3.919.bloodjournal873919","article-title":"Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors","volume":"87","author":"Moses","year":"1996","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.semdp.2017.04.009_bib70","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00002030-199606000-00002","article-title":"Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry","volume":"10","author":"Bagasra","year":"1996","journal-title":"AIDS"},{"issue":"4","key":"10.1053\/j.semdp.2017.04.009_bib71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0002-9394(89)90659-4","article-title":"Dual infection of retina with human immunodeficiency virus type 1 and cytomegalovirus","volume":"107","author":"Skolnik","year":"1989","journal-title":"Am J Opthalmol"},{"issue":"4","key":"10.1053\/j.semdp.2017.04.009_bib72","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.1992.146","article-title":"HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro","volume":"41","author":"Green","year":"1992","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.semdp.2017.04.009_bib73","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0092-8674(00)81393-8","article-title":"CD4-independent infection by HIV-2 is mediated by fusin\/CSCR4","volume":"87","author":"Endres","year":"1996","journal-title":"Cell"},{"issue":"7","key":"10.1053\/j.semdp.2017.04.009_bib74","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1074\/jbc.273.7.4282","article-title":"Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines","volume":"273","author":"Gupta","year":"1998","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1053\/j.semdp.2017.04.009_bib75","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/bbrc.1997.7890","article-title":"Chemokine receptor CXCR4 expression in endothelium","volume":"242","author":"Volin","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"14","key":"10.1053\/j.semdp.2017.04.009_bib76","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1097\/00002030-199910010-00017","article-title":"Natural history of HIV infection in the era of combination antiretroviral therapy","volume":"13","author":"Moore","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/j.semdp.2017.04.009_bib77","unstructured":"Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. US Department of Health and Human Services; 2015-04-08."},{"key":"10.1053\/j.semdp.2017.04.009_bib78","doi-asserted-by":"crossref","unstructured":"Rho M, Perazella M. Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients. Current Drug Safety. Volume 2 Issue 2 (Year).","DOI":"10.2174\/157488607780598269"},{"issue":"5","key":"10.1053\/j.semdp.2017.04.009_bib79","doi-asserted-by":"crossref","first-page":"e10452","DOI":"10.1371\/journal.pone.0010452","article-title":"Mortality reduction associated with HIV\/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funerals","volume":"5","author":"Mwagomba","year":"2010","journal-title":"PloS One"},{"key":"10.1053\/j.semdp.2017.04.009_bib80","doi-asserted-by":"crossref","unstructured":"Montaner JSG, Wood E, Kerr T, et al.\u00a0Expanded Highly Active Antiretroviral Therapy Coverage Among HIV-Positive Drug Users to Improve Individual and Public Health Outcomes. 55 (1); 2010:S5-S9.","DOI":"10.1097\/QAI.0b013e3181f9c1f0"},{"issue":"13","key":"10.1053\/j.semdp.2017.04.009_bib81","first-page":"853","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"333","author":"Palella","year":"1998","journal-title":"HIV Outpatient Study Invest Nejm"},{"issue":"19","key":"10.1053\/j.semdp.2017.04.009_bib82","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1157\/13088948","article-title":"Antiretroviral treatment associated life-threatening adverse events","volume":"126","author":"Moreno-Cuerda","year":"2006","journal-title":"Med Clin"},{"key":"10.1053\/j.semdp.2017.04.009_bib83","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Pallela","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2017.04.009_bib84","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.279.6.450","article-title":"Improved survival among HIV-infected individuals following initiation of antiretroviral therapy","volume":"279","author":"Hogg","year":"1998","journal-title":"J Am Med Assoc"},{"issue":"6","key":"10.1053\/j.semdp.2017.04.009_bib85","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/QAD.0b013e32802ef30c","article-title":"Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy","volume":"21","author":"Lima","year":"2007","journal-title":"AIDS"},{"key":"10.1053\/j.semdp.2017.04.009_bib86","first-page":"11","article-title":"Nephrotoxicity of HAART","volume":"562790","author":"Kalyesubula","year":"2011","journal-title":"AIDS Res Treat"},{"issue":"11","key":"10.1053\/j.semdp.2017.04.009_bib87","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ki.2010.344","article-title":"Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy","volume":"78","author":"Perazella","year":"2010","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.semdp.2017.04.009_bib88","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1681\/ASN.V191061","article-title":"Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections","volume":"1","author":"Berns","year":"1991","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.semdp.2017.04.009_bib89","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1086\/533468","article-title":"Severe renal dysfunction and risk factors associated with renal impairment of HIV-infected adults in Africa initiating antiretroviral therapy","volume":"46","author":"Reid","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1053\/j.semdp.2017.04.009_bib90","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1468-1293.2009.00693.x","article-title":"Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy","volume":"10","author":"Overton","year":"2009","journal-title":"HIV Med"},{"issue":"4","key":"10.1053\/j.semdp.2017.04.009_bib91","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1517\/14740338.7.4.389","article-title":"Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients","volume":"7","author":"Harris","year":"2008","journal-title":"Expert Opin Drug Saf"},{"issue":"8","key":"10.1053\/j.semdp.2017.04.009_bib92","first-page":"1082","article-title":"Urolithiasis in HIV-positive patients treated with atazanavir","volume":"45","author":"Couzigou","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1053\/j.semdp.2017.04.009_bib93","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/apc.2009.0326","article-title":"Prevalence and factors associated with renal dysfunction among HIV-infected patients","volume":"24","author":"Crum-Cianflone","year":"2010","journal-title":"AIDS Patient Care STDs"},{"issue":"11","key":"10.1053\/j.semdp.2017.04.009_bib94","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/ki.2010.318","article-title":"Tenofivir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological and mitochondrial abnormalities","volume":"78","author":"Herlitz","year":"2010","journal-title":"Kidney Int"},{"key":"10.1053\/j.semdp.2017.04.009_bib95","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/ajkd.2000.9791","article-title":"Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir","volume":"36","author":"Gagnon","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.semdp.2017.04.009_bib96","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.ki.5002134","article-title":"Nephrotoxicity of antiretroviral therapy in an HIV-infected patient","volume":"71","author":"Said","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.semdp.2017.04.009_bib97","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMc061892","article-title":"Atazanavir urolithiasis","volume":"355","author":"Chang","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2017.04.009_bib98","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1097\/01.aids.0000247571.88256.90","article-title":"Atazanavir urinary stones in an HIV-infected patient","volume":"20","author":"Pacanowski","year":"2006","journal-title":"AIDS"},{"key":"10.1053\/j.semdp.2017.04.009_bib99","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/QAD.0b013e32813aee35","article-title":"Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System","volume":"21","author":"Chan-Tack","year":"2007","journal-title":"AIDS"},{"key":"10.1053\/j.semdp.2017.04.009_bib100","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1097\/QAD.0b013e328303be50","article-title":"Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy","volume":"22","author":"Nelson","year":"2008","journal-title":"AIDS"},{"key":"10.1053\/j.semdp.2017.04.009_bib101","first-page":"296","article-title":"Abacavir-induced reversible Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome","volume":"52","author":"Ahmad","year":"2006","journal-title":"J Postgrad Med"},{"key":"10.1053\/j.semdp.2017.04.009_bib102","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00002030-199301000-00024","article-title":"Dideoxyinosine-associated nephrotoxicity","volume":"7","author":"Crowther","year":"1993","journal-title":"AIDS"},{"key":"10.1053\/j.semdp.2017.04.009_bib103","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.aids.0000168985.05209.b8","article-title":"Fanconi syndrome associated with didanosine therapy","volume":"19","author":"Izzedine","year":"2005","journal-title":"AIDS"},{"key":"10.1053\/j.semdp.2017.04.009_bib104","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1093\/ndt\/gfm467","article-title":"Fanconi syndrome and nephrogenic diabetes insipidus associated with didanosine therapy in HIV infection: a case report and literature review","volume":"22","author":"D'Ythurbide","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.semdp.2017.04.009_bib105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/QAD.0b013e32801120d1","article-title":"Efavirenz-associated podocyte damage","volume":"21","author":"Barbour","year":"2007","journal-title":"AIDS"},{"key":"10.1053\/j.semdp.2017.04.009_bib106","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00240-006-0052-6","article-title":"Efavirenz-induced urolithiasis","volume":"34","author":"Wirth","year":"2006","journal-title":"Urol Res"},{"key":"10.1053\/j.semdp.2017.04.009_bib107","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1097\/QAD.0b013e3282ef792f","article-title":"Efavirenz urolithiasis","volume":"21","author":"Izzedine","year":"2007","journal-title":"AIDS"},{"key":"10.1053\/j.semdp.2017.04.009_bib108","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/S0022-5347(05)65307-4","article-title":"Nelfinavir urinary stones","volume":"167","author":"Engeler","year":"2002","journal-title":"J Urol"},{"key":"10.1053\/j.semdp.2017.04.009_bib109","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/135965350801300514","article-title":"Same patient, new stone composition: amprenavir urinary stone","volume":"13","author":"Feicke","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1053\/j.semdp.2017.04.009_bib110","first-page":"555","article-title":"Renal calculi developing de novo in a patients taking saquinavir","volume":"9","author":"Green","year":"1998","journal-title":"Int J STD AIDS"},{"key":"10.1053\/j.semdp.2017.04.009_bib111","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00002030-200403050-00022","article-title":"Lopinavir\/ritonavir (Kaletra) and lithiasis: seven cases","volume":"18","author":"Doco-Lecompte","year":"2004","journal-title":"AIDS"},{"issue":"1","key":"10.1053\/j.semdp.2017.04.009_bib112","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.ackd.2009.07.009","article-title":"Antiretroviral medications: adverse effects on the kidney","volume":"17","author":"Jao","year":"2010","journal-title":"Adv Chronic Kidney Dis"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257017300540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257017300540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T08:00:00Z","timestamp":1658995200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257017300540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0740257017300540"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2017.04.009","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV associated kidney diseases: Clarifying concordance between renal failure in HIV infection and histopathologic manifestations at kidney biopsy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2017.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}